Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Melanoma 20Neoplasm Metastasis 8Leukemia, Myeloid, Acute 7Skin Neoplasms 6Ovarian Neoplasms 6Lymphoma, Non-Hodgkin 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Leukemia, Lymphocytic, Chronic, B-Cell 5Uveal Melanoma 4Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Triple Negative Breast Neoplasms 3Recurrence 3Rectal Neoplasms 3Pancreatic Neoplasms 3Mesothelioma, Malignant 3Lymphoma, Follicular 3Lymphoma 3Lung Neoplasms 3Leukemia 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Sarcoma 2Pleural Effusion, Malignant 2Neuroblastoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2

Interventions

fludarabine phosphate 1fludarabine 1artesunic acid 1artenimol 1artemisinin 1aldesleukin 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Granisetron 1Electrocardiography 1Droperidol 1Doxylamine 1Diphenoxylate 1Diphenhydramine 1Cyclophosphamide 1Codeine 1Cell Count 1Biopsy 1Atropine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Diseases × Interleukin-2 × 1 year × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡